Ironsides Asset Advisors’s Precision BioSciences DTIL Stock Holding History

Ironsides Asset Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-350	Closed	-$131K	–	97
2021 Q2	$131K	Sell	350 -107	-23%	-$32.1K	0.04%	97
2021 Q1	$142K	Buy	457 +88	+24%	+$30.8K	0.04%	90
2020 Q4	$92K	Sell	369 -34	-8%	-$8.33K	0.03%	81
2020 Q3	$74K	Sell	403 -96	-19%	-$19.1K	0.02%	73
2020 Q2	$125K	Hold	499	–	–	0.04%	75
2020 Q1	$90K	Buy	+499	New	+$131K	0.05%	65

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Ironsides Asset Advisors's DTIL Position: Q3 2021 in Review

Ironsides Asset Advisors sold out of Precision BioSciences (DTIL) in Q3 2021, closing a stake of 350 shares — an estimated $131K sold.

Ironsides Asset Advisors first reported a position in DTIL in Q1 2020 and held it in 6 quarters. The position peaked at $142K in Q1 2021. 132 funds tracked by Wall St. Rank hold DTIL as of Q3 2021.

Ironsides Asset Advisors reported no remaining Precision BioSciences position as of Q3 2021 after selling out during the quarter.
Ironsides Asset Advisors sold 350 Precision BioSciences shares in Q3 2021, an estimated $131K.
Ironsides Asset Advisors first reported a position in Precision BioSciences in Q1 2020 and held it in 6 quarters.
Ironsides Asset Advisors's Precision BioSciences position peaked at $142K in Q1 2021.
132 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2021.

Based on Ironsides Asset Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.